About UsEDP is committed to developing simple, accurate and cost-effective diagnostics that detect disease early.
EDP Biotech Corporation is a privately held medical device company focused on the development and commercialization of immunodiagnostic tests for humans and animals.
EDP performs research and develops products to identify and purify proteins present in the early stages of biological changes for production of in vitro diagnostic tests whose primary target is early detection.
EDP’s primary product, the new and improved 2nd Generation ColoMarker®, is a new biomarker assay to be used in the early detection of colorectal cancer.
EDP anticipates launching ColoMarker® in 2018 in Europe.
EDP Biotech Corporation is looking for interested Investors to help The ColoMarker® test is move past the research and development stage.
EDP Biotech Corporation is looking for qualified distributors of non-competitive IVD products for various regions internationally.